Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer
Titel:
Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer
Auteur:
Köstek, O. Demircan, N. C. Gökyer, A. Küçükarda, A. Sunal, B. S. Hacıoğlu, M. B. Eslame, H. Solak, S. Yılmaz, E. Uzunoğlu, S. Tunçbilek, N. Çiçin, İ. Erdoğan, B.